- ►annals.org [PDF] AB Rosen, MB Hamel, MC Weinstein, DM … - Annals of Internal Medicine, 2005 - Am Coll Physicians Background: Angiotensin-converting enzyme (ACE) inhibitors slow renal disease
progression and reduce cardiac morbidity and mortality in patients with
diabetes. Patients' out-of-pocket costs pose a barrier to using this ... Cited by 70 - Related articles - BL Direct - All 12 versions
- ►mass.gov [PDF] ME Chernew, AB Rosen, AM Fendrick - Health Affairs, 2007 - healthaff.highwire.org When everyone is required to pay the same out-of-pocket amount for health care
services whose benefits depend on patient characteristics, there is enormous
potential for both under- and overuse. Unlike most current health plan ... Cited by 56 - Related articles - BL Direct - All 25 versions
- ►ajmc.com [PDF] DP Goldman, GF Joyce, P Karaca-Mandic - American Journal of Managed Care, 2006 - works.bepress.com Results: The fraction of fully compliant patients fell by 6 to 10 percentage
points when copayments increased from $10 to $20, depending on patient risk (P <
.05). Full compliance was associated with 357 fewer hospitalizations ... Cited by 92 - Related articles - BL Direct - All 13 versions
AM Fendrick, DG Smith, ME Chernew, SN … - American Journal of Managed Care, 2001 - sph.umich.edu Prescription drug coverage is a critical agenda item on the healthcare policy
landscape. Increasing utilization of available drugs, cou- pled with the
sustained development and marketing of innovative products, is largely ... Cited by 123 - Related articles - View as HTML - BL Direct - All 7 versions
JJ Mahoney - Am J Manag Care, 2005 - ajmc.com Abstract Concerned about rising prevalence and costs of diabetes among its
employees, Pitney Bowes Inc recently revamped its drug benefit design to syner-
gize with ongoing efforts in its disease management and patient education ... Cited by 39 - Related articles - View as HTML - All 5 versions
AB Rosen - Journal of General Internal Medicine, 2006 - Springer Findings from the National Health and Nutrition Examination Survey 1999 to 2002
Allison B. Rosen, MD, MPH, ScD 1,2,3 1 Division of General Medicine, University
of Michigan Health Systems, Ann Arbor, MI, USA; ... Policy, University of ... Cited by 2 - Related articles - BL Direct - All 2 versions
AB Rosen - Journal of General Internal Medicine, 2006 - pubmedcentral.nih.gov Angiotensin-converting enzyme inhibitors (ACE) and angiotensin receptor blockers
(ARB) improve cardiovascular outcomes in high-risk individuals with diabetes.
Despite the marked benefit, it is unknown what percentage of patients with ... Cited by 12 - Related articles - All 6 versions
TB Gibson, RJ Ozminkowski, RZ Goetzel - Am J Manag Care, 2005 - ajmc.com Prescription drug expenditures are one of the fastest growing components of
national health expenditures.1 To control prescription drug costs, health plans
and employers have increased prescription drug cost-sharing amounts for ... Cited by 107 - Related articles - View as HTML - All 5 versions
[CITATION] Should patients receive secondary prevention medications for free after a myocardial …
NK Choudhry, J Avorn, EM Antman, S … - An economic analysis. Health Aff (Millwood), 2007 Cited by 18 - Related articles
- ►kff.org [PDF] T Rice, KY Matsuoka - Medical Care Research and Review, 2004 - mcr.sagepub.com Page 1. http://mcr.sagepub.com Medical Care Research and Review DOI:
10.1177/1077558704269498 2004; 61; 415 Med Care Res Rev Thomas ... Cited by 52 - Related articles - BL Direct - All 6 versions
